Winning Health Technology Group Co., Ltd. (SHE:300253)

SHE:300253 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,397	2,782	3,161	3,091	2,749	2,264
Other Revenue	0.45	0.44	2.47	1.38	0.94	2.23
Revenue	2,398	2,782	3,163	3,093	2,750	2,267
Revenue Growth (YoY)	-24.96%	-12.05%	2.28%	12.46%	21.34%	18.79%
Cost of Revenue	1,440	1,623	1,741	1,742	1,476	1,041
Gross Profit	957.98	1,159	1,423	1,351	1,275	1,226
Selling, General & Admin	481.91	545.37	653.83	707.67	585.95	464.12
Research & Development	251.31	264.63	333.3	313.77	255.67	229.45
Other Operating Expenses	-100.55	-107.76	-99.28	25.8	-79.54	-80.1
Operating Expenses	819.47	888.61	1,027	1,282	995.35	748.5
Operating Income	138.5	270.25	395.28	69.54	279.34	477.18
Interest Expense	-66.49	-66.76	-64.05	-59.63	-46.68	-9.88
Interest & Investment Income	8.17	10.14	43.09	20.62	11.8	105.82
Currency Exchange Gain (Loss)	-	-	-0.01	-	0	-0.02
Other Non Operating Income (Expenses)	-37.78	-5.32	0.78	-14.25	-22.38	-10.3
EBT Excluding Unusual Items	42.4	208.31	375.09	16.28	222.08	562.81
Impairment of Goodwill	-63.64	-63.64	-6.6	-22.94	-	-
Gain (Loss) on Sale of Investments	-85.59	-76.83	-50.46	-90.56	116.51	-34.69
Gain (Loss) on Sale of Assets	1.92	-0.28	-0.43	-0.52	0.18	0.23
Asset Writedown	-0.15	-0.09	-0.05	-0.31	-0.31	-0.69
Legal Settlements	-	-	-0.26	-	-	-
Other Unusual Items	11.35	19.49	23.46	136.6	34.72	18.5
Pretax Income	-93.7	86.96	340.75	38.54	373.17	546.16
Income Tax Expense	1.27	36.89	23.13	23.78	19.43	40.63
Earnings From Continuing Operations	-94.97	50.07	317.62	14.76	353.73	505.53
Minority Interest in Earnings	34.72	37.83	40.34	93.88	24.44	-14.43
Net Income	-60.24	87.89	357.96	108.64	378.17	491.1
Net Income to Common	-60.24	87.89	357.96	108.64	378.17	491.1
Net Income Growth	-	-75.45%	229.49%	-71.27%	-22.99%	23.26%
Shares Outstanding (Basic)	2,179	2,154	2,147	2,139	2,143	2,125
Shares Outstanding (Diluted)	2,179	2,160	2,195	2,143	2,147	2,138
Shares Change (YoY)	-0.41%	-1.60%	2.42%	-0.22%	0.44%	1.15%
EPS (Basic)	-0.03	0.04	0.17	0.05	0.18	0.23
EPS (Diluted)	-0.03	0.04	0.16	0.05	0.18	0.23
EPS Growth	-	-75.05%	221.70%	-71.21%	-23.34%	21.86%
Free Cash Flow	277.72	101.71	-128.53	-223.26	81.83	203.36
Free Cash Flow Per Share	0.13	0.05	-0.06	-0.10	0.04	0.10
Dividend Per Share	0.015	0.015	0.020	0.010	0.020	0.025
Dividend Growth	-25.00%	-25.00%	100.00%	-50.00%	-20.00%	30.21%
Gross Margin	39.95%	41.65%	44.97%	43.69%	46.35%	54.08%
Operating Margin	5.78%	9.71%	12.50%	2.25%	10.16%	21.05%
Profit Margin	-2.51%	3.16%	11.32%	3.51%	13.75%	21.67%
Free Cash Flow Margin	11.58%	3.66%	-4.06%	-7.22%	2.97%	8.97%
EBITDA	88.46	293.17	417.06	90.9	299.2	495.7
EBITDA Margin	3.69%	10.54%	13.18%	2.94%	10.88%	21.87%
D&A For EBITDA	-50.04	22.91	21.77	21.35	19.86	18.52
EBIT	138.5	270.25	395.28	69.54	279.34	477.18
EBIT Margin	5.78%	9.71%	12.50%	2.25%	10.16%	21.05%
Effective Tax Rate	-	42.42%	6.79%	61.71%	5.21%	7.44%
Revenue as Reported	2,398	2,782	3,163	3,093	2,750	2,267

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.